Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
Items 501–600 of 1,001
Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease
Cullen, K. M., Halliday, G. M., Double, K. L., Brooks, W. S., Creasey, H. M., & Broe, G. A. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00569-6 · Cited by 69
Kang, S. Y., Lee, K. Y., Koo, K. A., Yoon, J. S., Lim, S. W., Kim, Y. C., & Sung, S. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.07.029 · Cited by 65
Riederer, P. F., & Jellinger, K. A. (1983) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1983.tb01516.x · Cited by 66
Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger Type
Tomimoto, H., Ohtani, R., Shibata, M., Nakamura, N., & Ihara, M. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084553 · Cited by 66
Central Cholinergic Pathways Neuroanatomy and Some Behavioral Implications
Mesulam, M. M. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0925-3_15 · Cited by 72
Disruption of the grid cell network in a mouse model of early Alzheimer’s disease
Ying, J., Keinath, A. T., Lavoie, R., Vigneault, E., El Mestikawy, S., & Brandon, M. P. (2022) · Nature Communications · doi:10.1038/s41467-022-28551-x · Cited by 54
Transcriptome profiling in neurodegenerative disease
Courtney, E., Kornfeld, S., Janitz, K., & Janitz, M. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.08.018 · Cited by 71
Galasko, D. (1998) · European Journal of Neurology · doi:10.1111/j.1468-1331.1998.tb00444.x · Cited by 68
Aluminum silicate toxicity in cell cultures
Murphy, E. J., Roberts, E. R., & Horrocks, L. A. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90527-m · Cited by 64
Saccadic intrusions in Alzheimer-type dementia
Jones, A., Friedland, R. P., Koss, B., STARK, L. W., & Thompkins-Ober, B. A. (1983) · Journal of Neurology · doi:10.1007/bf00313742 · Cited by 65
Two anatomically specific classes of candidate cholinoceptive neurons in the rat olfactory bulb
Nickell, W. T., & Shipley, M. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04482.1988 · Cited by 66
Gabaergic regulation of the substantia innominata-cortical cholinergic pathway
Wood, P. L., & Richard, J. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90108-3 · Cited by 64
Cognition enhancement by the acetylcholine releaser DuP 996
Cook, L., Nickolson, V. J., Steinfels, G. F., Rohrbach, K. W., & DeNoble, V. J. (1990) · Drug Development Research · doi:10.1002/ddr.430190308 · Cited by 64
Davis, B. M., Mohs, R. C., Greenwald, B. S., Mathé, A. A., Johns, C. A., Horvath, T. B., & Davis, K. L. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb04184.x · Cited by 64
Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD)
Scheef, L., Grothe, M. J., Koppara, A., Daamen, M., Boecker, H., Biersack, H., Schild, H. H., Wagner, M., Teipel, S., & Jessen, F. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.101612 · Cited by 63
“It is well established that AD is associated with cell loss of the cholinergic basal forebrain nuclei leading to a reduced cholinergic innervation of the cortex (Davies and Maloney, 1976; Lehericy et al., 1993; McGeer et al., 1984; Perry, 1980; Ruberg et al., 1990; Whitehouse et al., 1981).”
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders
Digby, G. J., Shirey-Rice, J. K., & Conn, P. J. (2010) · Molecular BioSystems · doi:10.1039/c002938f · Cited by 69
Akondi, A. M., Mekala, S., Kantam, M. L., Trivedi, R., Chowhan, L. R., & Das, A. (2016) · New Journal of Chemistry · doi:10.1039/c6nj02869a · Cited by 63
Role of Sleep Disturbance in the Trajectory of Alzheimer’s Disease
Kang, D. W., Lee, C. U., & Lim, H. K. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.2.89 · Cited by 60
Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential
Loesche, A., Köwitsch, A., Lucas, S. D., Alhalabi, Z., Sippl, W., Al‐Harrasi, A., & Csük, R. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.12.013 · Cited by 64
Neurotrophic Factors in Neurodegeneration
Blesch, A. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00036.x · Cited by 67
Van Dam, D., Vloeberghs, E., Abramowski, D., Staufenbiel, M., & De Deyn, P. P. (2005) · CNS Spectrums · doi:10.1017/s1092852900010051 · Cited by 63
Neural Systems of the Non‐human Primate Forebrain Implicated in Memorya
Hoesen, G. W. V. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb37582.x · Cited by 66
Cholinergic therapy in dementia
Whitehouse, P. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04254.x · Cited by 63
Self-citationThe Nucleus Basalis of Meynert
Ezrin‐Waters, C., & Resch, L. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100035721 · Cited by 63
Alzheimer’s Disease and Stem Cell Therapy
Choi, S. S., Lee, S., Kim, S. U., & Lee, H. J. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.45 · Cited by 65
Acetylcholine modulates the temporal dynamics of human theta oscillations during memory
Gedankien, T., Tan, R. J., Qasim, S. E., Moore, H. C., McDonagh, D. L., Jacobs, J., & Lega, B. C. (2023) · Nature Communications · doi:10.1038/s41467-023-41025-y · Cited by 62
Invited Review Anticholinesterases: dramatic aspects of their use and misuse
Karczmar, A. G. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00123-x · Cited by 70
Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia
Iráizoz, I., Guijarro, J. L., Gonzalo, L. M., & Lacalle, S. D. (1999) · Acta Neuropathologica · doi:10.1007/s004010051068 · Cited by 62
Cortically projecting nucleus basalis neurons in rat are physiologically heterogeneous
Aston‐Jones, G., Shaver, R., & Dinan, T. G. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90192-7 · Cited by 62
Naito, R., & Tohda, C. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1892 · Cited by 61
A second wind for the cholinergic system in Alzheimer’s therapy
Douchamps, V., & Mathis, C. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000300 · Cited by 57
Morey, C. E., Cilo, M., Berry, J., & Cusick, C. (2003) · Brain Injury · doi:10.1080/0269905031000088586 · Cited by 61
Xuereb, J. H., Perry, E. K., Candy, J. M., Bonham, J. R., Perry, R. H., & Marshall, E. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90155-g · Cited by 61
Wenk, G. L., McGann, K., Hauss‐Wegrzyniak, B., & Rosi, S. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00545-1 · Cited by 69
Shim, T. S., Lee, J. H., Kim, S. Y., Lim, T., Kim, S. J., Kim, D. S., & Kim, W. D. (2001) · CHEST Journal · doi:10.1378/chest.120.5.1506 · Cited by 61
Hedreen, J. C., Bacon, S. J., Cork, L. C., Kitt, C. A., Crawford, G. D., Salvterra, P. M., & Price, D. L. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90183-0 · Cited by 61
Self-citationThe concept of subcortical dementia
Huber, S. J., & Paulson, G. W. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1312 · Cited by 61
Phytochemicals: A Promising Alternative for the Prevention of Alzheimer’s Disease
Koul, B., Farooq, U., Yadav, D., & Song, M. (2023) · Life · doi:10.3390/life13040999 · Cited by 64
Association of basal forebrain volumes and cognition in normal aging
Wolf, D. G. F., Grothe, M. J., Fischer, F. U., Heinsen, H., Kilimann, I., Teipel, S. J., & Fellgiebel, A. (2013) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.11.002 · Cited by 60
Autotransplantation of Bone Marrow-Derived Stem Cells as a Therapy for Neurodegenerative Diseases
Kan, I., Melamed, E., & Offen, D. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68976-8_10 · Cited by 64
The amygdala in Alzheimer's disease: Neuropathology and Alz 50 Immunoreactivity
Unger, J. W., Lapham, L. W., McNeill, T. H., Eskin, T. A., & Hamill, R. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90063-p · Cited by 61
Substance P and substance P receptor histochemistry in human neurodegenerative diseases
Kowall, N. W., Quigley, B. J., Krause, J. E., Lu, F., Kosofsky, B. E., & Ferrante, R. J. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90028-7 · Cited by 69
Meier-Ruge, W., & Bertoni-Freddari, C. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.1.1 · Cited by 60
Neuronal loss in the basal nucleus of meynert in progressive supranuclear palsy
Tagliavini, F., Pilleri, G., Gemignani, F., & Lechi, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697397 · Cited by 62
Kitchener, P. D., & Diamond, J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903350102 · Cited by 61
McKinney, M., Davies, P., & Coyle, J. T. (1982) · Brain Research · doi:10.1016/0006-8993(82)91133-7 · Cited by 60
Self-citationChallenging the Cholinergic Hypothesis in Alzheimer Disease
Davies, P. (1999) · JAMA · doi:10.1001/jama.281.15.1433 · Cited by 60
Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
Agarwal, M., Alam, R., Haider, M. K., Malik, M. Z., & Kim, D.-K. (2020) · Nanomaterials · doi:10.3390/nano11010059 · Cited by 63
Bai, Y., Tohda, C., Zhu, S., Hattori, M., & Komatsu, K. (2011) · Journal of Natural Medicines · doi:10.1007/s11418-011-0509-y · Cited by 62
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Peterson, A. C., & Li, C. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00127 · Cited by 64
Scarpa, M., Hesse, S., & Bradley, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2019.12.003 · Cited by 62
Darvesh, S., McDonald, R. S., Penwell, A., Conrad, S., Darvesh, K. V., Mataija, D., Gomez, G., Caines, A., Walsh, R., & Martin, E. V. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.059 · Cited by 59
Olfactory-related changes in Alzheimer's disease: A quantitative neuropathologic study
Reyes, P. F., Deems, D. A., & Suarez, M. G. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90310-8 · Cited by 62
Kordower, J. H., Bartus, R. T., Marciano, F. F., & Gash, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902790403 · Cited by 60
The basal nucleus of Meynert revised: the nerve cell number decreases with age
Lowes, P., Gertz, H., Ferszt, R., & Cervós‐Navarro, J. (1989) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(89)90066-6 · Cited by 59
From the Behavioral Pharmacology of Beta-Carbolines to Seizures, Anxiety, and Memory
Venault, P., & Chapouthier, G. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.48 · Cited by 59
Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease.
Nobakht, M., Hoseini, S. M., Mortazavi, P., Haghdoost, I. S., Esmaeilzade, B., Rahbar‐Roshandel, N., & Omidzahir, S. (2011) · Europe PMC (PubMed Central) · Cited by 76
Cantero, J. L., Záborszky, L., & Atienza, M. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw195 · Cited by 60
L3/Lhx8 is involved in the determination of cholinergic or GABAergic cell fate
Manabe, T., Tatsumi, K., Inoue, M., Matsuyoshi, H., Makinodan, M., Yokoyama, S., & Wanaka, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03261.x · Cited by 59
Tang, X.-C., Kindel, G. H., Kozikowski, A. P., & Hanin, I. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)01182-6 · Cited by 58
The ABC of Alzheimer's Disease: Behavioral Symptoms and Their Treatment
Grossberg, G. T. (2002) · International Psychogeriatrics · doi:10.1017/s1041610203008652 · Cited by 57
Sawada, M., Hirata, Y., Arai, H., Iizuka, R., & Nagatsu, T. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05582.x · Cited by 57
Disturbance of Recent Memory Function in Parkinsonian Patients on Anticholinergic Therapy
Koller, W. C. (1984) · Cortex · doi:10.1016/s0010-9452(84)80051-9 · Cited by 63
The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease
Cummings, J. L. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001917 · Cited by 57
Baroreflex function is reduced in Alzheimer’s disease: a candidate biomarker?
den Abeelen, A. S. S. M.-V., Lagró, J., Gommer, E. D., Reulen, J. P. H., & Claassen, J. A. H. R. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.010 · Cited by 63
Rho, H.-J., Kim, J., & Lee, S. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00047 · Cited by 61
Correlates of aggressive behavior in dementia
Hall, K. A., & O’Connor, D. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000286 · Cited by 65
Cell Loss from the Nucleus Basalis of Meynert in Alzheimer's Disease
Doucette, R., Fisman, M., Hachinski, V. C., & Mersky, H. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037070 · Cited by 67
Nabeshima, T. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62424-3 · Cited by 57
The rostral mesencephalon in Parkinson's disease and Alzheimer's disease
Hunter, S. (1985) · Acta Neuropathologica · doi:10.1007/bf00688956 · Cited by 58
Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons
Wenk, G. L., McGann, K., Mencarelli, A., Hauss‐Wegrzyniak, B., Soldato, P. D., & Fiorucci, S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00523-9 · Cited by 57
Alonso, J. R., & Amaral, D. G. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903550202 · Cited by 57
Casu, M. A. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.3.329 · Cited by 54
Immunohistochemical localization of β-nerve growth factor receptors in the forebrain of the rat
Dawbarn, D., Allen, S. J., & Semenenko, F. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)91175-4 · Cited by 57
Novel amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity
Gallrein, C., Iburg, M., Michelberger, T., Koçak, A., Puchkov, D., Liu, F., Ayala, S., Nayak, T., Schierle, G. S. K., & Kirstein, J. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101907 · Cited by 59
Small, G., & Jarvik, L. F. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91339-3 · Cited by 56
Donepezil: a clinical review of current and emerging indications
Román, G. C., & Rogers, S. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.1.161 · Cited by 58
Gau, J., Steinhilb, M. L., Kao, T.-C., D’Amato, C. J., Gaut, J. R., Frey, K. A., & Turner, R. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64893-6 · Cited by 60
Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases
Schwarz, Š., Lucas, S. D., Sommerwerk, S., & Csük, R. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.04.046 · Cited by 60
Effects of baicalein on β-amyloid peptide-(25–35)-induced amnesia in mice
Wang, S.-Y., Wang, H., Chi, C., Chen, C., & Liao, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.029 · Cited by 56
Recent preclinical evidence advancing cell therapy for Alzheimer's disease
Borlongan, C. V. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.024 · Cited by 61
Potential therapeutic uses of mecamylamine and its stereoisomers
Nickell, J. R., Grinevich, V. P., Siripurapu, K. B., Smith, A. M., & Dwoskin, L. P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.005 · Cited by 59
Moss, D. E., Perez, R. G., & Kobayashi, H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160733 · Cited by 55
Jhou, J.-F., & Tai, H.-C. (2017) · Neurology and Therapy · doi:10.1007/s40120-017-0070-z · Cited by 51
Activation of Muscarinic Receptors Inhibits औ-Amyloid Peptide-induced Signaling in Cortical Slices
Gu, Z., Zhong, P., & Yan, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209892200 · Cited by 56
Aston‐Jones, G., Shaver, R., & Dinan, T. G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90323-3 · Cited by 55
Retrograde Amnesia in Parkinson’s Disease
Freedman, M., Rivoira, P., Butters, N., Sax, D. S., & Feldman, R. G. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710004556x · Cited by 55
Counts, S. E., He, B., Che, S., Ginsberg, S. D., & Mufson, E. J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1196 · Cited by 52
Zampagni, M., Wright, D., Cascella, R., D’Adamio, G., Casamenti, F., Evangelisti, E., Cardona, F., Goti, A., Nacmias, B., Sorbi, S., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.012 · Cited by 58
Kapková, P., Alptüzün, V., Frey, P., Erciyas, E., & Holzgrabe, U. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.034 · Cited by 58
A circuit view of deep brain stimulation in Alzheimer’s disease and the possible mechanisms
Yu, D., Yan, H., Zhou, J., Yang, X., Lu, Y., & Han, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0334-4 · Cited by 58
Iráizoz, I., Lacalle, S. D., & Gonzalo, L. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90198-w · Cited by 54
Cummings, J. L., Nadel, A., Masterman, D. L., & Cyrus, P. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400211 · Cited by 57
Salehi, A., Dubelaar, E. J. G., Mulder, M., & Swaab, D. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11445 · Cited by 52
Immunocytochemical localization of somatostatin in human brain
Bennett‐Clarke, C. A., & Joseph, S. A. (1986) · Peptides · doi:10.1016/0196-9781(86)90109-9 · Cited by 56
Neuropharmacologic and Behavioral Actions of Clonidine: Interactions With Central Neurotransmitters
Buccafusco, J. J. (1992) · International review of neurobiology · doi:10.1016/s0074-7742(08)60691-1 · Cited by 58
Regulation of Choline Acetyltransferase
Salvoterra, P. M., & Vaughn, J. E. (1989) · International review of neurobiology · doi:10.1016/s0074-7742(08)60278-0 · Cited by 55
Metrifonate treatment of AD: Influence of APOE genotype
Farlow, M. R., Cyrus, P. A., Nadel, A., Lahiri, D. K., Brashear, A., & Gulanski, B. (1999) · Neurology · doi:10.1212/wnl.53.9.2010 · Cited by 53
The cortical relationships of certain basal ganglia and the cholinergic basal forebrain nuclei
Pearson, R. C. A., Gatter, K. C., & Powell, T. P. S. (1983) · Brain Research · doi:10.1016/0006-8993(83)90638-8 · Cited by 55
NAKAI, T., Yamada, K., & Mizoguchi, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115549 · Cited by 53
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.